恒大汽车所持3000万美元股权被冻结 财联社11月13日电，天眼查法律诉讼信息显示，近日，恒大新能 源汽车投资控股集团有限公司新增一条股权冻结信息，股权被执行的企业为恒大新能源汽车（江苏）有 限公司，冻结股权数额3000万美元，冻结期限自2024年11月11日至2027年11月10日，执行法院为苏州工 业园区人民法院。 ...

证券时报网讯，恒生指数开盘基本持平报20592.74点，恒生科技指数涨0.57%，恒生中国企业指数涨 0.09%。 旭辉控股集团涨近6%，77.88%债权人签订或加入境外债务重组支持协议。 新明中国复牌涨近267%。 恒大汽车跌超22%，潜在股份转让交易停止。 力高集团复牌跌近58%。 校对：王朝全 ...

热点聚焦 1、李强上周五主持召开国务院常务会议，交流经济形势和一揽子增量政策落实调研情况。会议强调， 要紧紧围绕努力实现全年经济社会发展目标，持续抓好一揽子增量政策的落地落实。 2、十四届全国人大常委会第三十二次委员长会议25日上午在北京人民大会堂举行。赵乐际委员长主持 会议。会议决定，十四届全国人大常委会第十二次会议11月4日至8日在北京举行。 3、国家统计局发布数据，1—9月份，全国规模以上工业企业实现利润总额52281.6亿元，同比下降 3.5%。1—9月份，规模以上工业企业中，国有控股企业实现利润总额17235.9亿元，同比下降6.5%；股 份制企业实现利润总额38872.3亿元，下降4.9%；外商及港澳台投资企业实现利润总额13036.4亿元，增 长1.5%；私营企业实现利润总额14227.2亿元，下降0.6%。 4、香港特区财政司司长陈茂波发表司长随笔称，将带领由金融及创科界代表组成的商务代表团，前往 沙特阿拉伯利雅得进行三天访问。此行的重点活动之一，是见证首两只在沙特阿拉伯交易所上市、追踪 港股的交易所买卖基金(ETF)，这意味着沙特的投资者将可在其熟悉的交易和监管环境下，轻松地透过 买卖当地挂 ...

恒大汽车：潜在卖方决定停止与潜在买方就可能的股权转让进行讨论 申请由10月28日起复牌 财联社10 月25日电，恒大汽车港交所公告，公司董事会宣布，于2024年10月25日，接获潜在卖方的通知，彼等已 决定停止与潜在买方有关潜在股份转让的所有讨论，并已决定不继续进行潜在股份转让。 概未就潜在股份转让订立任何买卖协议。 因此，预期将不会与潜在买方（ 或其指定的另一方 ）签订融资协议，或以其他方式向本公司提供任何 融资。 公司已向联交所申请由2024年10月28日上午9时正起恢复买卖股份。 ...

AUTO NDE 中國恒大新能源汽車集團有限公司 (於香港註冊成立之有限公司) (股份代號 : 00708) 2024 中期報告 f 00 恒驰与 0 O ............... ............... ............ ........ . . . . . : . . . . . 0 9 .. . . . . . . . . . . . . . . . . . . . . . ............... ............... 000000 ...... to 100 . . . . ..................... . 目錄 02 董事及委員會 03 公司及股東資料 04–05 董事會報告 06–11 管理層討論與分析 12–17 企業管治及其他資料 獨立核數師報告 18–19 中期簡明綜合損益及其他全面收益表 20–21 中期簡明綜合財務狀況表 22–23 中期簡明綜合權益變動表 24–25 中期簡明綜合現金流量表 26 27–54 中期財務資料附註 董事及委員會 梁家進先生（於2024年8月5日獲委任） 王克楠先生（於2024年8月5日獲委任） | --- ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失 承擔任何責任。 CHINA EVERGRANDE NEW ENERGY VEHICLE GROUP LIMITED 中 國 恒 大 新 能 源 汽 車 集 團 有 限 公 司 （ 於香港註冊成立之有限公司） （股份代號：708） 截至2024年6月30日止六個月 中期業績公告 中期業績 中國恒大新能源汽車集團有限公司董事（「董事」）組成之董事會（「董事會」）欣然呈列本公司 及 其 附 屬 公 司 截 至2024 年 6 月 30 日 止 六個 月 之 未 經 審 核 中 期 業 績 ， 連 同呈 列 於 本 公 告 以 作 參考之比較數字。 財務摘要 1. 截至2024年6 月30日，本集團資產總額人民幣16,369 百萬元；負債總額人民幣74,350 百 萬元，其中：借款人民幣26,590百萬元，貿易及其他應付款人民幣46,695百萬元，其他 負債人民幣1,065百萬元。 2. 報 告 期 內 ， 本 集 團 收 入 ...

Financial Performance and Losses - Revenue for the reporting period surged by 900.04% to RMB 1,340.15 million, driven by a significant increase in car and car parts sales from RMB 60.63 million to RMB 146.32 million[9] - Gross loss decreased by 45.44% to RMB 51.21 million compared to the previous year[10] - The company recorded a net loss from continuing operations of RMB 10,934.18 million, a 26.38% reduction compared to the previous year[16] - The company completed the sale of its health management business on May 12, 2023, resulting in a loss from discontinued operations of RMB 1,060.93 million[17] - The company reported a net loss of approximately RMB 11,995 million for the year 2023[91] - The company's net current liabilities amounted to approximately RMB 38,077 million as of December 31, 2023[91] - The cumulative losses and shareholders' losses as of December 31, 2023, were approximately RMB 110,841 million and RMB 37,693 million, respectively[91] - The company's cash and cash equivalents as of December 31, 2023, were only approximately RMB 129 million[91] - The company's auditor, PricewaterhouseCoopers, expressed a disclaimer of opinion due to significant uncertainties regarding the company's ability to continue as a going concern[91] - The company recorded a net loss of approximately RMB 11,995 million for the year ended December 31, 2023[120] - The company's net current liabilities amounted to RMB 38,077 million as of December 31, 2023[120] - The company's cash and cash equivalents were only RMB 129 million as of December 31, 2023[120] - The company faces significant uncertainty regarding its ability to continue as a going concern[120] - The company's directors have taken measures to improve liquidity and financial conditions, but the outcome remains uncertain[120] - The company's financial statements were prepared on a going concern basis, but the appropriateness of this assumption is uncertain[120] - The company's financial statements do not include adjustments that would be necessary if the going concern assumption were inappropriate[121] - The company's future cash flows indicate significant uncertainty about its ability to continue operations[121] - Revenue from continuing operations in 2023 was RMB 1,340,148 thousand, compared to RMB 134,011 thousand in 2022, representing a significant increase[126] - Gross loss for 2023 was RMB 51,211 thousand, an improvement from the gross loss of RMB 93,858 thousand in 2022[126] - Operating loss for 2023 was RMB 8,962,165 thousand, a reduction from the operating loss of RMB 12,141,468 thousand in 2022[126] - Net loss attributable to owners of the company for 2023 was RMB 11,934,199 thousand, compared to RMB 27,660,362 thousand in 2022[128] - The company's total comprehensive loss for 2023 amounted to RMB 12,241,721 thousand, with an annual loss of RMB 11,934,199 thousand and other comprehensive losses of RMB 307,522 thousand[132] - The company's accumulated losses as of December 31, 2023, stood at RMB 110,840,530 thousand, an increase from RMB 98,906,331 thousand at the beginning of the year[132] - The company's total loss for 2023 was RMB 12,302,632 thousand, including non-controlling interests of RMB 60,911 thousand[132] - The company reported a loss of RMB 11,995 million for the year ended December 31, 2023, compared to a loss of RMB 27,664 million in 2022[139] - Cumulative losses and shareholders' losses as of December 31, 2023, were RMB 110,841 million and RMB 37,693 million, respectively[139] - Cash and cash equivalents as of December 31, 2023, were RMB 129 million, down from RMB 220 million in 2022[139] Liabilities and Borrowings - Total liabilities as of December 31, 2023, amounted to RMB 72,543.32 million, with borrowings increasing by RMB 498.91 million to RMB 26,484.08 million compared to the previous year[7] - Trade and other payables increased by RMB 12,215.56 million to RMB 43,011.74 million as of December 31, 2023[8] - The company's total borrowings and lease liabilities amounted to RMB 26.815 billion as of December 31, 2023, with a debt-to-asset ratio of 76.94%[24] - Unpaid debts and overdue commercial bills amounted to RMB 9.447 billion and RMB 3.401 billion, respectively, as of December 31, 2023[27] - The company is negotiating with banks and other financial institutions to extend existing loans and corporate bonds due within 12 months after December 31, 2023, to meet financial obligations[95] - The company is negotiating with banks and financial institutions to extend existing loans and bonds due within 12 months after December 31, 2023[139] - Total liabilities as of December 31, 2023, were RMB 72,543,319 thousand, down from RMB 183,872,117 thousand in 2022[130] Assets and Impairments - Property, plant, and equipment, intangible assets, and right-of-use assets impairment losses totaled RMB 4,811.10 million, primarily due to impairments on intangible assets and construction in progress[15] - Financial asset impairment losses amounted to RMB 929.70 million, mainly due to provisions for other receivables and prepayments to third parties[14] - Total assets as of December 31, 2023, were RMB 34,850,768 thousand, a decrease from RMB 115,221,255 thousand in 2022[129] - Property, plant, and equipment decreased to RMB 12,440,969 thousand in 2023 from RMB 14,536,900 thousand in 2022[129] - Intangible assets dropped significantly to RMB 786,835 thousand in 2023 from RMB 4,477,860 thousand in 2022[129] - Cash and cash equivalents decreased to RMB 128,824 thousand in 2023 from RMB 219,941 thousand in 2022[129] - Total equity attributable to owners of the company improved to a negative RMB 37,644,349 thousand in 2023 from a negative RMB 68,600,774 thousand in 2022[129] - The company's total equity as of December 31, 2023, was RMB 37,644,349 thousand, compared to RMB 68,600,774 thousand at the beginning of the year[132] - The company's non-controlling interests as of December 31, 2023, amounted to RMB 48,202 thousand, a decrease from RMB 50,088 thousand at the beginning of the year[132] - The company's total equity attributable to owners of the company as of December 31, 2023, was RMB 45,072,080 thousand, compared to RMB 2,181,456 thousand at the beginning of the year[132] Operational Costs and Expenses - Sales and marketing costs rose by 29.97% to RMB 254.91 million due to increased promotional and brand promotion expenses for the Hengchi 5 model[12] - Administrative expenses decreased by 10.18% to RMB 2,350.22 million, primarily due to staff reductions, salary cuts, and reduced R&D expenditures[13] - The company employed 1,342 staff as of December 31, 2023, with total employee costs of RMB 706.95 million during the reporting period[28] - The company is implementing plans to alleviate liquidity pressure and improve financial conditions, including cost control measures such as temporary salary reductions and leave arrangements for employees, as well as reducing promotional expenses[94] - The company is implementing cost control measures, including production and workforce optimization, restructuring, and exploring new markets[139] New Energy Vehicle Production and Sales - Global production and sales of new energy vehicles in 2023 reached 9.587 million and 9.495 million units, respectively, with year-on-year growth of 35.8% and 37.9%, and a market share of 31.6%[18] - The company has 270 R&D personnel as of December 31, 2023, and completed four OTA upgrades for the Hengchi 5 model during the reporting period[19] - Cumulative production of Hengchi 5 at the Tianjin manufacturing base reached 1,700 units by the end of 2023[20] - Cumulative deliveries of new energy vehicles exceeded 1,389 units by the end of 2023, with 18 operational sales stores in 14 key cities[21] - The company produced a total of 1,700 units of the Hengchi 5 model at its Tianjin manufacturing base by the end of 2023[69] - Cumulative deliveries of new energy vehicles exceeded 1,389 units by the end of 2023[70] - The company operated 18 sales outlets in 14 key cities, including Guangzhou, Tianjin, Beijing, Wuhan, and Chongqing[70] - The company has 270 R&D personnel, focusing on improving the quality, functionality, and performance of the Hengchi 5 model, with four OTA upgrades completed during the reporting period[68] - The company suspended the development and base construction of power batteries due to financial constraints, focusing resources on the vehicle sector[70] - The company's R&D efforts included pre-research on the second-generation platform and optimization of the Hengchi 6 and Hengchi 7 models, though progress was impacted by funding issues[68] - The company actively reduced operating costs during the reporting period[70] Strategic Investments and Funding - The company plans to introduce strategic investors to secure funding for future development, including the launch of Hengchi 5, 6, and 7 models and expansion into overseas markets[23] - The company entered into a share subscription agreement with Newton Group on August 14, 2023, to issue 6,177,106,404 new shares at HK$0.6297 per share, totaling HK$3,889,723,903 (approximately $500 million), which would result in Newton Group holding approximately 27.50% of the enlarged issued share capital[36] - The share subscription agreement with Newton Group expired on December 31, 2023, as the parties did not agree to extend the final deadline[36] - The company received RMB 200 million in interest-free and secured transitional funding from Newton (Zhejiang) Automobile Co., Ltd. during the reporting period[36] - The company entered into a debt-to-equity conversion agreement with China Evergrande Group, Hui Ka Yan, Xinxin (BVI) Limited, Ding Yumei, and Haobang Limited on August 14, 2023, to issue 5,441,305,702 new shares at HK$3.84 per share, totaling HK$20,894,613,901.15[37] - The debt-to-equity conversion agreement expired on December 31, 2023, as the parties did not agree to extend the final deadline[38] - The company is controlling capital expenditures and discussing plans to introduce strategic investors, including restructuring plans post-investment[95] - The company's ability to continue as a going concern depends on successful execution of restructuring and financing plans[141] Board and Governance - The company's board of directors includes executive directors Xiao En (Chairman), Liu Yongzhuo, and Qin Liyong, along with independent non-executive directors Zhou Chengyan, Guo Jianwen, and Xie Wu[40] - The company's subsidiaries have no significant transactions, arrangements, or contracts in which the directors or their related parties have a material interest[42] - Xiao En, the Chairman and Executive Director, has over 30 years of business experience and holds a Master's degree in Economic Law from Southwest University of Political Science and Law[43] - Liu Yongzhuo, the President of the company, has over 20 years of corporate management experience and holds a Master's degree in Engineering Management from Wuhan University of Science and Technology[43] - Qin Liyong, the Vice President, has over 16 years of experience in large enterprise management and holds a Master's degree in Management Science and Engineering from Tongji University[43] - Zhou Chengyan, an independent non-executive director, has over 30 years of corporate finance experience and is a member of several professional accounting and financial organizations[44] - Guo Jianwen, an independent non-executive director, is a senior physician with extensive experience in traditional Chinese medicine and holds a Doctorate in Clinical Medicine[45] - Xie Wu, an independent non-executive director, has 25 years of clinical experience in traditional Chinese medicine, specializing in nephrology and blood purification[45] - Cao Hui, the General Manager of the Financial Center, holds senior accountant qualifications and has extensive experience in finance and accounting within the company[46] - The Board of Directors held 4 meetings during the year, with all executive directors attending all meetings[77][81] - The Audit Committee held 1 meeting to review and approve the annual financial statements for the year ended December 31, 2023[84] - The company has 3 executive directors and 2 independent non-executive directors, with no non-executive directors[78] - All directors participated in training courses to update their knowledge and skills, complying with the Code on Continuing Professional Development[82] - The Audit Committee reviewed the effectiveness of the internal control system and risk management with management and external auditors[84] - The company has established 4 Board Committees: Audit, Remuneration, Nomination, and Corporate Governance Committees[80] - The Audit Committee recommended the reappointment of PricewaterhouseCoopers as the external auditor for the fiscal year ending December 31, 2023[84] - The company has a formal schedule listing matters requiring Board approval, including financial policies, dividend distribution, and major structural changes[77] - The Audit Committee reviewed the Group's non-exempt continuing connected transactions for the year[84] - The company complies with the requirement that independent non-executive directors constitute at least one-third of the Board[76] - The company's board of directors reviewed the cash flow forecast prepared by management, which covers a period of at least 12 months from December 31, 2023[92] - The company's board of directors confirmed that all directors complied with the Model Code for Securities Transactions during the year[89] - The company's board of directors is responsible for ensuring the proper preparation and timely publication of the consolidated financial statements[90] - The board of directors is responsible for risk management and internal control systems, ensuring their effectiveness and supervising their design, implementation, and monitoring[96] - The audit committee reviews the risk management framework and monitors its effectiveness, including overseeing the design and implementation of risk management and internal control systems[97] - The company is continuously improving its risk management system architecture, with a clear organizational structure and defined responsibilities for risk management[98] - Senior management is responsible for promoting the construction of the risk management system, regularly reviewing policies, and reporting significant risk information to the audit committee[99] - Updated risk assessment standards based on internal and external environmental changes, focusing on business nature, strategic goals, and management risk preferences[100] - Established a continuous risk management cycle: risk identification, control implementation, follow-up, and optimization[103] - Conducted a comprehensive review of the 2023 risk management system, updating risk assessment standards and databases[104] - Implemented a COSO-based internal control framework with five interdependent elements: control environment, risk assessment, control activities, information and communication, and monitoring activities[105] - Annual review of risk management and internal control systems by the Board of Directors, covering financial, operational, and compliance monitoring[108] - Audit fees for the year amounted to RMB 5.90 million, with non-audit services fees at RMB 0.55 million[110] - Regular communication with shareholders through annual general meetings, website updates, investor briefings, and roadshows[111] - Attendance of key committee chairs and external auditors at annual general meetings to address shareholder inquiries[112] Related-Party Transactions - Total sales of new energy vehicles to China Evergrande Group's subsidiaries in 2023 amounted to approximately RMB 15,066,725.65[62] - The company has no intention of entering into new transactions for new energy vehicle sales, landscaping services, or material procurement in 2024 and beyond[61][62] - The top five customers accounted for less than 30% of total sales, and the top five suppliers accounted for less than 30% of total procurement in 2023[58] - A related-party transaction involving the sale of subsidiaries Huibao Limited and Flaming Ace Limited was completed on May 12, 2023, for a total consideration of RMB 2[59] - Liu Yongzhuo holds 20,600,000 shares of China Evergrande Group and 548,500 shares of Evergrande Property Group, representing 0.16% and 0.00% stakes, respectively[53][54] - Qin Liyong holds 4,036,000 shares of China Evergrande Group, of which 2,936,000 shares are held directly and 1,100,000 shares are held through share options[53][54] - Zhou Chengyan directly holds 1,000,000 shares of China Evergrande Group, representing a 0.01% stake[53][54] - The company confirmed that all independent non-executive directors are independent under the Hong Kong Listing Rules[57] - No management contracts for the company's business operations were entered into during the year[58] - The company's related-party transactions with China Evergrande Group were deemed fair and reasonable, conducted under normal commercial terms[63] Share-Based Payments and Stock Options - The company granted stock options to directors and designated employees, with a maximum of 10% of the issued share capital as of June 6, 2018, and any grants exceeding this limit require shareholder approval[34] - As of December 31, 2023, there were 221,515,000 unexercised stock options, a decrease from 388,600,000 as of December 31, 2022, with no new options granted, 167,085,000 options expired, and no options exercised during the reporting period[35] - Total number of employee stock options at the beginning of 2023 was 132,640,000, with 60,380,000 options expiring during the year, leaving 72,260,000 options outstanding as of December 31, 2023[49] - Employee stock options granted on November 6, 2020, have an exercise price of HKD 23.05 per share, with a market price of HKD

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失 承擔任何責任。 CHINA EVERGRANDE NEW ENERGY VEHICLE GROUP LIMITED 中 國 恒 大 新 能 源 汽 車 集 團 有 限 公 司 （ 於香港註冊成立之有限公司） （股份代號：708） 截至2023年12月31日止年度 全年業績公告 及 持續關連交易 全年業績 中國恒大新能源汽車集團有限公司董事（「董事」）組成之董事會（「董事會」）欣然呈列本公司 及其附屬公司截至2023年12月31日止年度（「報告期」）之經審核全年業績，連同呈列於本公 告以作參考之比較數字。 財務摘要 1. 截 至 2023 年 12 月 31 日 ， 本 集 團 資 產 總 額 人 民 幣 348.51 億 元 ； 負 債 總 額 人 民 幣 725.43 億 元，其中：借款人民幣264.84億元，貿易及其他應付款人民幣430.12億元，其他負債人 民幣30.47億元。 2. 報告期內，本 集團收入為人民幣 ...

EVERGRANDE AUTO 中國恒大新能源汽車集團有限公司 (於香港註冊成立之有限公司) (股份代號：00708) 中期報告 2023 t 00 恒驰S 0 A p 00 it 78 睡碰5 00 E e 3 1 I 董事及委員會 02 公司及股東資料 03 董事會報告 04–06 管理層討論與分析 07–12 企業管治及其他資料 13–17 獨立核數師報告 18–19 中期簡明綜合資產負債表 20–21 中期簡明綜合全面收益表 22–23 中期簡明綜合權益變動表 24–25 中期簡明綜合現金流量表 26 簡明綜合中期財務資料附註 27–58 目 錄 中期報告2023 02 謝武先生 董事及委員會 | --- | --- | |-------------------------|---------------------------| | | | | 執行董事 | 企業管治委員會 | | 肖恩先生 （董事長） | 周承炎先生 （委員會主席） | | 劉永灼先生 （副董事長） | 肖恩先生 | | 秦立永先生 | 郭建文先生 | | 獨立非執行董事 | 授權代表 | | 周承炎先生 | 肖恩先生 | | 郭 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失 承擔任何責任。 CHINA EVERGRANDE NEW ENERGY VEHICLE GROUP LIMITED 中 國 恒 大 新 能 源 汽 車 集 團 有 限 公 司 （ 於香港註冊成立之有限公司） （股份代號：708） 截至2023年6月30日止六個月 中期業績公告 中期業績 中國恒大新能源汽車集團有限公司董事（「董事」）組成之董事會（「董事會」）欣然呈列本公司 及 其 附 屬 公 司 截 至2023 年 6 月 30 日 止 六個 月 之 未 經 審 核 中 期 業 績 ， 連 同呈 列 於 本 公 告 以 作 參考之比較數字。 財務摘要 1、 本集團持作出售之終止經營之業務（ 即剝離地產項目）於2023年5月12日完成，導致財務 報表的淨負債減少人民幣431.39億元。截至2023年6月30日，本公司淨負債降至人民幣 328.4億元。 2、 截 至 2023 年 6 月 30 日 ， 本 集 團 資 產 總 ...